Placebo, XPF-010
XPF-010-B301
Phase 3 small_molecule active
Quick answer
Placebo, XPF-010 for Depressive episodes associated with Bipolar disorder I or II (Bipolar Depression) is a Phase 3 program (small_molecule) at Xenon Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xenon Pharmaceuticals
- Indication
- Depressive episodes associated with Bipolar disorder I or II (Bipolar Depression)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active